is the leading oncology channel committed to improving cancer communication and education with the goal of optimising patient care and outcomes. ecancer's programmes offer the healthcare community a wealth of free resources to support continued professional development. ecancer and SIOG have delivered a series of interviews of SIOG key opinion leaders and conference speakers in Amsterdam. Click here to watch them.
This service has been kindly supported by an unrestricted grant from Janssen Oncology.
![]() | ![]() | ![]() | ![]() |
![]() | ![]() | ![]() | ![]() |
![]() | ![]() | ![]() | ![]() |
![]() | ![]() | ![]() | ![]() |
![]() | ![]() | ![]() | ![]() |
![]() | ![]() | ![]() |
CME accreditation
The SIOG 2018 Annual Conference was granted 19 European CME credits (ECMEC®s) by the European Accreditation Council for Continuing Medical Education (EACCME®).
Accreditation Statement
Accreditation by the EACCME® confers the right to place the following statement in all communication materials including the event website, the event programme and the certificate of attendance. The following statements must be used without revision:
“The SIOG 2018 Annual Conference, Amsterdam, Netherlands, 16/11/2018-18/11/2018 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 16 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.”
Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA
Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at www.ama-assn.org/go/internationalcme.
Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.
Industry partners
The International Society of Geriatric Oncology would like to thank all sponsors for their support towards the SIOG 2018 Annual Conference.
BRONZE SPONSORS
CONFERENCE SUPPORTERS
Industry sponsored satellite session
The following industry sponsored satellite session is being organised by Sanofi Genzyme.
Friday, November 16, 2018 - 14:45-15:45 - Forum Room
Improving the management of senior adults with prostate cancer
Chairs: Jean-Pierre Droz (FR), Nicolas Mottet (FR)
14:45-15:00 Management of prostate cancer - what's new? - Nicolas Mottet (FR)
15:00-15:15 Metastatic prostate cancer in senior adults - a closer look to daily practice - Amit Bahl (GB)
15:15-15:30 Updated SIOG guidelines for the management of senior adults with prostate cancer - Jean-Pierre Droz (FR)
15:30-15:45 Discussion and questions
-------------------------------
The following industry sponsored satellite session is being organised by Pierre Fabre Oncology.
Sunday, November 18, 2018 - 10:30-11:30 - Forum Room
Chemotherapy optimisation in elderly MBC and NSCLC patients: clinical considerations
Chair: Matti Aapro (CH)
10:30-10:35 Introduction: Guidance from SIOG guidelines - Matti Aapro (CH)
10:35-10:55 Good sense approach in the selection of chemotherapy agents and schedules in Metastatic Breast Cancer - José Manuel Lopez Vega (SP)
10:55-11:15 How can we improve chemotherapy outcomes in advanced NSCLC? - Andrea Camerini (IT)
11:15-11:25 Panel discussion
11:25-11:30 Take-home message - Matti Aapro (CH)
Educational grants
We gratefully acknowledge the following company for its unrestricted educational grant towards our scientific programme.
The following session has been supported by and unrestricted education grant by Celgene.
Saturday, November 17, 2018 – 15:00-16:00 – Forum Room
Immuno-Oncology (IO) chemotherapy combinations and its impact on older breast and lung cancer patients
Chairs: Ravindran Kanesvaran (SG), Hans Wildiers (BE)
15:00-15:15 - Chemo-Immuno-Oncology combination in the treatment of metastatic lung cancer in older adults - Ravindran Kanesvaran (SG)
15:15-15:30 - Chemo-Immuno-Oncology combination in the treatment of metastatic breast cancer in older adults - Hans Wildiers (BE)
15:30-15:45 - Management of Chemo- Immuno-Oncology combination toxicities in older adults - William Tew (US)
15:45-16:00 - Discussion and questions